Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
about
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@ast
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@en
type
label
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@ast
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@en
prefLabel
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@ast
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@en
P2093
P2860
P50
P1433
P1476
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.
@en
P2093
Björn Hansson
Catarina Rippe
Dorota Kotowska
Olga Göransson
P2860
P304
P356
10.1371/JOURNAL.PONE.0173412
P407
P577
2017-03-09T00:00:00Z